https://doi.org/10.1016/j.critrevonc.2024.104324
C
Chiara Miggiano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
261
Citations
8
h-index
6
i10-index
Chiara Miggiano is an academic researcher from Humanitas University. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Cancer-related Molecular Pathways & Radiomics and Machine Learning in Medical Imaging. The author has an h-index of 8, co-authored 19 publications.
ORCID: 0000-0002-6580-673XPapers by this author
worksCyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
2024 · Critical Reviews in Oncology/Hematology · 60 citations
Opportunities and Challenges of Synthetic Data Generation in Oncology
2023 · JCO Clinical Cancer Informatics · 35 citations
https://doi.org/10.1200/cci.23.00045
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
2023 · Cancers · 20 citations
https://doi.org/10.3390/cancers15112933
HR+/HER2– de novo metastatic breast cancer: a true peculiar entity?
2023 · Drugs in Context · 17 citations
https://doi.org/10.7573/dic.2022-12-2
Beyond failure of endocrine-based therapies in HR+/HER2 negative advanced breast cancer: What before chemotherapy? A glimpse into the future
2025 · Critical Reviews in Oncology/Hematology · 3 citations
https://doi.org/10.1016/j.critrevonc.2025.104634
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat